On the public citation graph

Soluble Periostin is a Potential Biomarker for Chemotherapy Efficacy Monitoring in Advanced Breast Cancer

https://doi.org/10.2139/ssrn.4087372
0 signed · 31 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/ijc.25591openalex-extracted
Increased expression and serum levels of the stromal cell‐secreted protein periostin in breast cancer bone metastases
inferredcites →https://doi.org/10.1002/jcp.29184openalex-extracted
Prognostic value of periostin in multiple solid cancers: A systematic review with meta‐analysis
inferredcites →https://doi.org/10.1002/path.4747openalex-extracted
Periostin promotes immunosuppressive premetastatic niche formation to facilitate breast tumour metastasis
inferredcites →https://doi.org/10.1007/s10549-015-3666-yopenalex-extracted
The relationship between local recurrence and death in early-stage breast cancer
inferredcites →https://doi.org/10.1007/s10549-020-05570-0openalex-extracted
High serum levels of periostin are associated with a poor survival in breast cancer
inferredcites →https://doi.org/10.1016/j.cell.2020.10.036openalex-extracted
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy
inferredcites →https://doi.org/10.1016/j.ejca.2008.10.026openalex-extracted
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
inferredcites →https://doi.org/10.1016/j.ejca.2015.09.015openalex-extracted
Survival in familial and non-familial breast cancer by age and stage at diagnosis
inferredcites →https://doi.org/10.1016/j.jss.2008.12.042openalex-extracted
The Expression Analysis of Periostin in Human Breast Cancer
inferredcites →https://doi.org/10.1016/j.rcl.2017.06.004openalex-extracted
Screening for Breast Cancer
inferredcites →https://doi.org/10.1023/a:1021899904332openalex-extracted
Elevated Serum Periostin Levels in Patients with Bone Metastases from Breast but not Lung Cancer
inferredcites →https://doi.org/10.1038/s41598-018-22340-7openalex-extracted
Periostin blockade overcomes chemoresistance via restricting the expansion of mesenchymal tumor subpopulations in breast cancer
inferredcites →https://doi.org/10.1038/srep07069openalex-extracted
Periostin suppression induces decorin secretion leading to reduced breast cancer cell motility and invasion
inferredcites →https://doi.org/10.1042/bj2940271openalex-extracted
Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I
inferredcites →https://doi.org/10.1111/cas.13712openalex-extracted
Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer
inferredcites →https://doi.org/10.1111/jcmm.12636openalex-extracted
Periostin down‐regulation attenuates the pro‐fibrogenic response of hepatic stellate cells induced by TGF ‐β1
inferredcites →https://doi.org/10.1148/radiol.2019182947openalex-extracted
Breast MRI: State of the Art
inferredcites →https://doi.org/10.1158/1541-7786.mcr-15-0079openalex-extracted
Tumor Cell-Derived Periostin Regulates Cytokines That Maintain Breast Cancer Stem Cells
inferredcites →https://doi.org/10.1177/0022034515581372openalex-extracted
Mechanical Force–induced TGFB1 Increases Expression of SOST/POSTN by hPDL Cells
inferredcites →https://doi.org/10.1186/s12885-016-2139-yopenalex-extracted
The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome
inferredcites →https://doi.org/10.1186/s12885-020-07761-wopenalex-extracted
Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer
inferredcites →https://doi.org/10.1186/s12957-020-01907-7openalex-extracted
Survival outcomes of neoadjuvant versus adjuvant chemotherapy in triple-negative breast cancer: a meta-analysis of 36,480 cases
inferredcites →https://doi.org/10.1200/jop.2015.005215openalex-extracted
Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
inferredcites →https://doi.org/10.1359/jbmr.1999.14.7.1239openalex-extracted
Identification and Characterization of a Novel Protein, Periostin, with Restricted Expression to Periosteum and Periodontal Ligament and Increased Expression by Transforming Growth Factor β
inferredcites →https://doi.org/10.1371/journal.pone.0187635openalex-extracted
Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma
inferredcites →https://doi.org/10.1371/journal.pone.0227356openalex-extracted
An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies
inferredcites →https://doi.org/10.21037/cco.2020.01.06openalex-extracted
Biomarkers of neoadjuvant/adjuvant chemotherapy for breast cancer
inferredcites →https://doi.org/10.21203/rs.3.rs-20324/v1openalex-extracted
inferredcites →https://doi.org/10.21203/rs.3.rs-35645/v2openalex-extracted
inferredcites →https://doi.org/10.3389/fonc.2018.00225openalex-extracted
Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression
inferredcites →https://doi.org/10.3390/ijms160817181openalex-extracted
Prognostic Value of Preoperative Serum Levels of Periostin (PN) in Early Breast Cancer (BCa)
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.